Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Eli Lilly & Co. (LLY) has a market cap of $824.12B with year-over-year revenue growth of +44.7%. Net margin stands at 31.7%. The stock trades at a P/E ratio of 39.9.
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, LLY posted revenue growth of +44.7% and trades at a P/E of 39.9.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.